Am. J. Respir. Crit. Care Med., Volume 160, Number 5, November 1999, 1682-1687

Predictors of Outcome and Long-term Survival in Patients with Pleural Infection

CHRISTOPHER W. H. DAVIES, SUSAN E. KEARNEY, FERGUS V. GLEESON, and ROBERT J. O. DAVIES

Osler Chest Unit and Department of Radiology, Churchill Hospital Site, Oxford Radcliffe Hospital, Headington, Oxford, United Kingdom

In pleural infection, medical treatment failure (chest-tube drainage and antibiotics) requires surgery and increases mortality. It would be helpful to predict which patients will fail this approach. We examined clinical predictors in 85 consecutive patients with pleural infection receiving chest drainage and intrapleural fibrinolytics, and recorded age, length of history, antibiotic delay and choice, time to drainage, blood/pleural fluid (PF) bacteriology, PF pH, lactate dehydrogenase (LDH), glucose and appearance, effusion size, pleural thickness on computed tomographic (CT) scan, and survival from time of drainage. Failures (surgery/death) were compared with successes. There were 13 (15%) medical failures. PF purulence was more frequent in medical failures (10 of 13 versus 29 of 72 successes, p < 0.02 chi-square). Absence of purulence was a useful predictor of success (positive predictive value [PPV] 93%). Purulence was not useful in predicting medical failure (PPV 26%). There was a trend for positive blood culture to predict failure (5 of 13 failures versus 11 of 72 successes, p = 0.05 chi-square), but no significant differences in other endpoints. Twelve (14%) patients died in follow-up, all with comorbidity within 400 d after drainage. Probability of survival at 4 yr was 86%. Of endpoints considered in this study, PF purulence was the only useful predictor of outcome with medical therapy in pleural infection. There is good long-term survival from pleural infection. Davies CWH, Kearney SE, Gleeson FV, Davies RJO. Predictors of outcome and long-term survival in patients with pleural infection.

This article has been cited by other articles:

				E. Paramasivam and A. Bodenham Pleural fluid collections in critically ill patients CEACCP, February 1, 2007; 7(1): 10 - 14. [Full Text] [PDF]

				Managing empyema in adults DTB, March 1, 2006; 44(3): 17 - 21. [Abstract] [Full Text] [PDF]

				Y. Tokuda, D. Matsushima, G. H. Stein, and S. Miyagi Intrapleural Fibrinolytic Agents for Empyema and Complicated Parapneumonic Effusions: A Meta-analysis Chest, March 1, 2006; 129(3): 783 - 790. [Abstract] [Full Text] [PDF]

				A Medford and N Maskell Pleural effusion Postgrad. Med. J., November 1, 2005; 81(961): 702 - 710. [Abstract] [Full Text] [PDF]

				N. A. Maskell, C. W.H. Davies, A. J. Nunn, E. L. Hedley, F. V. Gleeson, R. Miller, R. Gabe, G. L. Rees, T. E.A. Peto, M. A. Woodhead, et al. U.K. Controlled Trial of Intrapleural Streptokinase for Pleural Infection N. Engl. J. Med., March 3, 2005; 352(9): 865 - 874. [Abstract] [Full Text] [PDF]

				I M Balfour-Lynn, E Abrahamson, G Cohen, J Hartley, S King, D Parikh, D Spencer, A H Thomson, D Urquhart, and on behalf of the Paediatric Pleural Diseases Subco BTS guidelines for the management of pleural infection in children Thorax, February 1, 2005; 60(suppl_1): i1 - i21. [Full Text] [PDF]

				T N Hilliard, A J Henderson, and S C L. Hewer Management of parapneumonic effusion and empyema Arch. Dis. Child., October 1, 2003; 88(10): 915 - 917. [Abstract] [Full Text] [PDF]

				C W H Davies, F V Gleeson, and R J O Davies BTS guidelines for the management of pleural infection Thorax, May 1, 2003; 58(90002): ii18 - 28. [Full Text]